Clinical Trial Update: Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluated whether an opioid receptor antagonist could prevent stimulant-induced euphoria in individuals with ADHD. The study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Stimulant-induced Euphoria

Drugs mentioned

• Opioid receptor antagonist

Snippet

Sponsor: Massachusetts General Hospital | Conditions: ADHD, Stimulant-Induced Euphoria | Phase 4 | Status: COMPLETED | Results posted: 2016-11-30